Page last updated: 2024-09-05

cinnamophilin and cyclic gmp

cinnamophilin has been researched along with cyclic gmp in 1 studies

Compound Research Comparison

Studies
(cinnamophilin)
Trials
(cinnamophilin)
Recent Studies (post-2010)
(cinnamophilin)
Studies
(cyclic gmp)
Trials
(cyclic gmp)
Recent Studies (post-2010) (cyclic gmp)
130522,3463334,062

Protein Interaction Comparison

ProteinTaxonomycinnamophilin (IC50)cyclic gmp (IC50)
Phosphodiesterase Bos taurus (cattle)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)2.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)2.4

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ko, FN; Lee, JY; Teng, CM; Wu, TS; Yu, SM1

Other Studies

1 other study(ies) available for cinnamophilin and cyclic gmp

ArticleYear
Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
    European journal of pharmacology, 1994, Apr-11, Volume: 256, Issue:1

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta, Thoracic; Calcium Channel Blockers; Cyclic AMP; Cyclic GMP; Female; Guaiacol; Guinea Pigs; In Vitro Techniques; Lignans; Male; Muscle, Smooth; Muscle, Smooth, Vascular; Plants, Medicinal; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Thromboxane; Taiwan; Thromboxane A2

1994